We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+2.25%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$182M
AUM Growth
-$31.9M
(-15%)
Cap. Flow
-$30.2M
Cap. Flow
% of AUM
-16.61%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
696
New
183
Increased
134
Reduced
159
Closed
219
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.9M |
| 2 |
HOLX
Hologic
HOLX
|
+$4.77M |
| 3 |
TXNM
TXNM Energy Inc
TXNM
|
+$3.68M |
| 4 |
Tesla
TSLA
|
+$2.33M |
| 5 |
Eli Lilly
LLY
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FYBR
Frontier Communications
FYBR
|
+$5.48M |
| 2 |
Linde
LIN
|
+$4.58M |
| 3 |
Blackrock
BLK
|
+$3.51M |
| 4 |
Motorola Solutions
MSI
|
+$3.35M |
| 5 |
TSMC
TSM
|
+$2.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.61% |
| 2 | Industrials | 17.14% |
| 3 | Technology | 15.62% |
| 4 | Healthcare | 13.23% |
| 5 | Consumer Discretionary | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Beam Global
BEEM
$22.9M
| $26.4K | 0.01% |
+17,949
| New | +$28.3K |
|
452
Evolent Health
EVH
$654M
| $25.6K | 0.01% |
+11,206
| New | +$35.5K |
|
453
Pulmonx
LUNG
$59.1M
| $25.5K | 0.01% |
+19,780
| New | +$32.7K |
|
454
Lucid Diagnostics
LUCD
$181M
| $24.7K | 0.01% |
21,516
+3,077
| +17% | +$3.92K |
|
455
Richtech Robotics
RR
$358M
| $24.7K | 0.01% |
+11,807
| New | +$36.3K |
|
456
ProKidney
PROK
$332M
| $24.5K | 0.01% |
+13,696
| New | +$29.1K |
|
|
GLDG
457
GoldMining Inc
GLDG
$180M
| $24.3K | 0.01% |
20,397
+9,241
| +83% | +$13.9K |
|
458
ZipRecruiter
ZIP
$323M
| $23.7K | 0.01% |
12,861
-2,049
| -14% | -$5.03K |
|
|
ABTC
459
American Bitcoin Corp
ABTC
$397M
| $23.6K | 0.01% |
+1,699
| New | +$32.7K |
|
460
EVgo
EVGO
$237M
| $23.1K | 0.01% |
+13,431
| New | +$35.9K |
|
461
Zevia
ZVIA
$122M
| $22.9K | 0.01% |
19,600
-24,412
| -55% | -$38.8K |
|
462
Fate Therapeutics
FATE
$324M
| $22.2K | 0.01% |
18,524
+8,066
| +77% | +$9.82K |
|
|
SGMO
463
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $22.2K | 0.01% |
89,866
-57,325
| -39% | -$22.8K |
|
464
8x8 Inc
EGHT
$267M
| $19.6K | 0.01% |
+11,819
| New | +$24.2K |
|
465
Cardiff Oncology
CRDF
$68.3M
| $19.1K | 0.01% |
11,802
-899
| -7% | -$1.85K |
|
466
JELD-WEN Holding
JELD
$101M
| $17.8K | 0.01% |
+14,393
| New | +$31.5K |
|
467
SunPower Inc
SPWR
$102M
| $13.5K | 0.01% |
10,612
-23,821
| -69% | -$35.8K |
|
468
Hain Celestial
HAIN
$50.6M
| $11.3K | 0.01% |
+16,214
| New | +$15.1K |
|
469
Bioceres Crop Solutions
BIOX
$22.3M
| $9.82K | 0.01% |
22,075
+9,135
| +71% | +$6.93K |
|
470
ParaZero Technologies
PRZO
$13.5M
| $9.69K | 0.01% |
12,571
-2,153
| -15% | -$2.48K |
|
471
Standard BioTools
LAB
$350M
| $9.44K | 0.01% |
+10,268
| New | +$12.4K |
|
472
Nerdy
NRDY
$106M
| $8.82K | ﹤0.01% |
+10,807
| New | +$10.4K |
|
473
MaxCyte
MXCT
$133M
| $8.47K | ﹤0.01% |
+12,060
| New | +$11.3K |
|
474
Accuray
ARAY
$30.8M
| $7.92K | ﹤0.01% |
+20,418
| New | +$12.6K |
|
475
Tenaya Therapeutics
TNYA
$177M
| $7.76K | ﹤0.01% |
+11,208
| New | +$8.27K |
|
Similar funds
NED
CFG
CFG
WCM
OWA
TFP
HIMS
AFS
R Squared's Q1 2026 Portfolio in Review
As of Q1 2026, R Squared held 696 positions worth $182M, down 15% from $214M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
R Squared withdrew a net $30.2M in Q1 2026, closing 219 positions and reducing 159 holdings. Its most notable exit was Frontier Communications, an estimated $5.48M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
Against the trend, R Squared opened a new position in Apple worth $4.78M.
- R Squared's largest Q1 2026 buy was Apple: 18,818 shares worth $4.78M.
- R Squared added most to Hologic in Q1 2026, an estimated $4.77M increase.
- R Squared's biggest Q1 2026 reduction was Linde, cutting an estimated $4.58M.
- R Squared fully exited Frontier Communications in Q1 2026, selling an estimated $5.48M.
- R Squared's ten largest holdings make up 17% of its $182M portfolio in Q1 2026.
- R Squared opened 183 new positions and closed 219 in Q1 2026.
- R Squared's portfolio value fell 15% quarter-over-quarter to $182M.
Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.